Evaluation of First-Line Coagulation Tests in Highly Active Antiretroviral Therapy (HAART) Naïve and Treated Group of HIV Infected Subjects
Ngwu Amauche Martina, Ozoemena Chiadikobi Lawrence, Umeh Okechukwu Elijah, Ugwu Ifeanyichukwu Basil & Ozoume Chibuike Innocent · Journal of Advances in Medical and Pharmaceutical Sciences · 2024
Background: Coagulation disorders are common in patients with Human Immunodeficiency virus (HIV). Coagulation abnormalities occur as a result of HIV-related thrombocytopenia, induced hepatotoxicity due to highly active antiretroviral therapy (HAART) that impairs liver function an...
Open access
Research Article
10.9734/jamps/2024/v26i3672